Mice subcutaneously immunized with the nanoformulation exhibited a high magnitude of tumor specific CD8+ T cells.[49] Along with magnitude, the functional quality and longevity of CD8+ T cells are critically important for efficient and durable anti‐tumor immunity. The gene discussed is CD8A; the disease is neoplasm.